Scientific Reports· 2026Q1
The clinical and imaging comparisons between sellar extraventricular neurocytoma and nonfunctional pituitary macroadenoma
- 0citations
- Q1SCImago
- 2026year
Short summary
Sellar extraventricular neurocytomas (EVNs) are more commonly solid lesions with obvious MR enhancement and eccentric cavernous sinus involvement (89.5% and 84.2% respectively) compared to nonfunctional pituitary macroadenomas (55.6% and 44.4%).
AI-generated from the title and abstract; the full text is not read.
Key points
- Sellar EVNs are characterized by solid lesions (78.9%) and obvious MR enhancement (89.5%).
- Nonfunctional pituitary macroadenomas are more frequently cystic (51.9%) and show intratumoral hemorrhage (29.6%).
- EVNs exhibit higher rates of eccentric cavernous sinus involvement (84.2%) and dural tail sign (68.4%).
- Despite higher gross total resection rates for macroadenomas (59.3%), recurrence and progression-free survival were similar between groups.
AI-generated from the title and abstract; the full text is not read.
Abstract
We aimed to explore the clinical and imaging features of sellar extraventricular neurocytoma (EVN) through a comparison between sellar EVN and nonfunctional pituitary macroadenoma. 19 cases of EVN and 27 cases of nonfunctional pituitary macroadenoma were retrospectively included, and their clinical and imaging findings were analyzed. Compared with sellar EVNs, nonfunctional pituitary macroadenomas were more common with cystic changes (51.9% vs. 21.1%, P = 0.035), intratumoral hemorrhage (29.6% vs. 0, P = 0.027), and vesicle signs (33.3% vs. 0, P = 0.015). Compared with nonfunctional pituitary macroadenomas, sellar EVNs were common with solid lesions (78.9% vs. 48.1%, P = 0.035), obvious MR enhancement (89.5% vs. 55.6%, P = 0.014), eccentric cavernous sinus involvement (84.2% vs. 44.4%, P = 0.007), and dural tail sign (68.4% vs. 22.2%, P = 0.002). Compared with nonfunctional pituitary macroadenoma, sellar EVN was more common with subtotal resection (37.0% vs. 68.4%, P = 0.036) and postoperative radiotherapy (14.8% vs. 78.9%, P < 0.001). However, there was no significant difference in recurrence and progression-free survival between the two groups, although the gross total resection rate of nonfunctional pituitary macroadenomas was higher (59.3% vs. 21.1%, P = 0.010). Solid lesions with obvious MR enhancement, dural tail sign, and eccentric cavernous sinus involvement could suggest sellar EVN in the condition of negative pituitary hormone. The clinical and imaging comparisons between sellar EVN and nonfunctional pituitary macroadenoma were helpful for clinical diagnosis and treatment.
The authors' abstract, as published at the source. Scientific Reports, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Endocrinology, Diabetes and Metabolism
Endocrinology, Diabetes and MetabolismMedicine